Pfizer Inc

New York, NY · CIK 78003 · 13F filing filed 2026-08-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

Legal entityPFIZER INC. (US)

$170.4m reported value -28.7% vs Q1 2026

17positions

95.8%in top 10

0 new 0 added 3 reduced 1 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	ALLOGENE THERAPEUTICS INC COM ALLO	ALLO	22,032,040	$46.9m27.55%	27.55%	Unchanged
2	CELCUITY INC COM CELC	CELC	295,652	$29.6m17.35%	17.35%	Unchanged
3	ARVINAS INC COM ARVN	ARVN	3,457,815	$27.7m16.24%	16.24%	Unchanged
4	PYXIS ONCOLOGY INC COMMON STOCK PYXS	PYXS	7,032,770	$19.5m11.43%	11.43%	Unchanged
5	WAVE LIFE SCIENCES LTD SHS 96663EUR	96663EUR	1,875,000	$10.9m6.42%	6.42%	Unchanged
6	BIOHAVEN LTD COM BHVN	BHVN	505,645	$8.0m4.70%	4.70%	Unchanged
7	CARIBOU BIOSCIENCES INC COM CRBU	CRBU	4,690,431	$7.9m4.63%	4.63%	Unchanged
8	SPERO THERAPEUTICS INC COM SPRO	SPRO	2,362,348	$5.3m3.13%	3.13%	Unchanged
9	ZENTALIS PHARMACEUTICALS INC COM ZNTL	ZNTL	953,834	$3.9m2.26%	2.26%	Unchanged
10	ORIC PHARMACEUTICALS INC COM ORIC	ORIC	372,904	$3.6m2.09%	2.09%	Reduced -4.4m	-4,407,497 -92.2%
11	CARDIFF ONCOLOGY INC COM CRDF	CRDF	2,411,575	$3.0m1.77%	1.77%	Unchanged
12	ZURA BIO LTD CLASS A ORD SHS ZURA	ZURA	538,841	$2.9m1.69%	1.69%	Reduced -2.3m	-2,300,072 -81.0%
13	AGOMAB THERAPEUTICS NV SPONSORED ADS AGMB	AGMB	75,000	$1.0m0.61%	0.61%	Unchanged
14	BOLT BIOTHERAPEUTICS INC COM NEW BOLT	BOLT	31,305	$133.8k0.08%	0.08%	Unchanged
15	NEXTCURE INC COM NEW NXTC	NXTC	44,347	$73.0k0.04%	0.04%	Reduced -109.0k	-109,007 -71.1%
16	GINKGO BIOWORKS HOLDINGS INC CL A NEW DNA	DNA	2,928	$30.0k0.02%	0.02%	Unchanged
17	SENSEONICS HLDGS INC COM COM		2,171	$12.4k0.01%	0.01%	Unchanged

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
Q32 BIO INC QTTB	QTTB	101,618	$736.7k101.6k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

Company	Ticker	Stake	Change	Schedule	Last filed
ALLOGENE THERAPEUTICS INC ALLO · 13D · filed 2026-02-13	ALLO	9.0%≈ $45.8m		13D	2026-02-13